Restoring the Drive: Ariadne Bio Launches to Tackle Parkinson’s-Associated Apathy with Novel Serotonin Agonist
The landscape of neuropsychiatric drug development is notoriously difficult to navigate, characterized by high failure rates and a tendency to...
